The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2018 Jun 8

PMID 29874886

Citations 35

Authors

Nathan K P Wong

Stephen J Nicholls

Joanne T M Tan

Christina A Bursill

Affiliations

Soon will be listed here.

Abstract

Almost 600 million people are predicted to have diabetes mellitus (DM) by 2035. Diabetic patients suffer from increased rates of microvascular and macrovascular complications, associated with dyslipidaemia, impaired angiogenic responses to ischaemia, accelerated atherosclerosis, and inflammation. Despite recent treatment advances, many diabetic patients remain refractory to current approaches, highlighting the need for alternative agents. There is emerging evidence that high-density lipoproteins (HDL) are able to rescue diabetes-related vascular complications through diverse mechanisms. Such protective functions of HDL, however, can be rendered dysfunctional within the pathological milieu of DM, triggering the development of vascular complications. HDL-modifying therapies remain controversial as many have had limited benefits on cardiovascular risk, although more recent trials are showing promise. This review will discuss the latest data from epidemiological, clinical, and pre-clinical studies demonstrating various roles for HDL in diabetes and its vascular complications that have the potential to facilitate its successful translation.

Citing Articles

The relationship between the atherogenic index of plasma and postoperative myocardial injury following non-cardiac surgery under general anaesthesia: a retrospective cohort study.

Zhou Y, Zhong L, Liao Y, Zhong Y BMC Cardiovasc Disord. 2025; 25(1):75.

PMID: 39901072 PMC: 11789311. DOI: 10.1186/s12872-025-04534-w.

Association of serum Metrnl levels and high-density lipoprotein cholesterol in patients with type 2 diabetes mellitus: a cross-sectional study.

Zhou C, Zeng J, Gao X, Chen D, Zhu Q, Feng B PeerJ. 2024; 12:e18264.

PMID: 39421410 PMC: 11485050. DOI: 10.7717/peerj.18264.

A comprehensive analysis of the role of native and modified HDL in ER stress in primary macrophages.

Bobek J, Stuttgen G, Sahoo D Front Cardiovasc Med. 2024; 11:1448607.

PMID: 39328237 PMC: 11424405. DOI: 10.3389/fcvm.2024.1448607.

The Atherogenic Index of Plasma is a Predictor for Chronic Total Occlusion and Coronary Collateral Circulation Formation in CTOs Patients.

Li Y, Feng Y, Zhong Y, Li S, Lin J, Fang P Rev Cardiovasc Med. 2024; 24(10):305.

PMID: 39077586 PMC: 11273106. DOI: 10.31083/j.rcm2410305.

Association between blood lipids and diabetes mellitus in older Chinese adults aged 65 years or older: a cross-sectional analysis of residents' electronic health records.

Lin T, Zhao Y, Yang Q, Wang W, Jiang X, Qiu Y Lipids Health Dis. 2024; 23(1):167.

PMID: 38835037 PMC: 11149314. DOI: 10.1186/s12944-024-02160-7.

References

Brodde M, Korporaal S, Herminghaus G, Fobker M, Van Berkel T, Tietge U . Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI: role of negatively charged phospholipids. Atherosclerosis. 2011; 215(2):374-82. DOI: 10.1016/j.atherosclerosis.2010.12.026. View

Muller C, Salvayre R, Negre-Salvayre A, Vindis C . HDLs inhibit endoplasmic reticulum stress and autophagic response induced by oxidized LDLs. Cell Death Differ. 2010; 18(5):817-28. PMC: 3131925. DOI: 10.1038/cdd.2010.149. View

Tangirala R, Tsukamoto K, Chun S, Usher D, Pure E, Rader D . Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation. 1999; 100(17):1816-22. DOI: 10.1161/01.cir.100.17.1816. View

Niu W, Qi Y . Circulating cholesteryl ester transfer protein and coronary heart disease: mendelian randomization meta-analysis. Circ Cardiovasc Genet. 2015; 8(1):114-21. DOI: 10.1161/CIRCGENETICS.114.000748. View

Sattar N, Preiss D, Robinson J, Djedjos C, Elliott M, Somaratne R . Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data. Lancet Diabetes Endocrinol. 2016; 4(5):403-10. DOI: 10.1016/S2213-8587(16)00003-6. View

Costa P, Soares R . Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox. Life Sci. 2013; 92(22):1037-45. DOI: 10.1016/j.lfs.2013.04.001. View

Pan B, Ma Y, Ren H, He Y, Wang Y, Lv X . Diabetic HDL is dysfunctional in stimulating endothelial cell migration and proliferation due to down regulation of SR-BI expression. PLoS One. 2012; 7(11):e48530. PMC: 3487724. DOI: 10.1371/journal.pone.0048530. View

Landray M, Haynes R, Hopewell J, Parish S, Aung T, Tomson J . Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med. 2014; 371(3):203-12. DOI: 10.1056/NEJMoa1300955. View

Ganda O . Statin-induced diabetes: incidence, mechanisms, and implications. F1000Res. 2016; 5. PMC: 4926726. DOI: 10.12688/f1000research.8629.1. View

10.

Morton J, Zoungas S, Li Q, Patel A, Chalmers J, Woodward M . Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study. Diabetes Care. 2012; 35(11):2201-6. PMC: 3476889. DOI: 10.2337/dc12-0306. View

11.

Stenkula K, Lindahl M, Petrlova J, Dalla-Riva J, Goransson O, Cushman S . Single injections of apoA-I acutely improve in vivo glucose tolerance in insulin-resistant mice. Diabetologia. 2014; 57(4):797-800. PMC: 3940850. DOI: 10.1007/s00125-014-3162-7. View

12.

Ng M, Wadham C, Sukocheva O . The role of sphingolipid signalling in diabetes‑associated pathologies (Review). Int J Mol Med. 2017; 39(2):243-252. PMC: 5358714. DOI: 10.3892/ijmm.2017.2855. View

13.

Stancu C, Toma L, Sima A . Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis. Cell Tissue Res. 2012; 349(2):433-46. DOI: 10.1007/s00441-012-1437-1. View

14.

Gantman A, Fuhrman B, Aviram M, Hayek T . High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx. Biochem Biophys Res Commun. 2009; 391(1):523-8. DOI: 10.1016/j.bbrc.2009.11.091. View

15.

Sampaio E, Barbosa D, Mazzuco T, Nunes V, Passarelli M, Nakandakare E . Impaired antioxidant action of high density lipoprotein in patients with type 1 diabetes with normoalbuminuria and microalbuminuria. Diabetes Res Clin Pract. 2013; 99(3):321-6. DOI: 10.1016/j.diabres.2012.12.012. View

16.

Puyal J, Petremand J, Dubuis G, Rummel C, Widmann C . HDLs protect the MIN6 insulinoma cell line against tunicamycin-induced apoptosis without inhibiting ER stress and without restoring ER functionality. Mol Cell Endocrinol. 2013; 381(1-2):291-301. DOI: 10.1016/j.mce.2013.08.016. View

17.

Thakker D, Nair S, Pagada A, Jamdade V, Malik A . Statin use and the risk of developing diabetes: a network meta-analysis. Pharmacoepidemiol Drug Saf. 2016; 25(10):1131-1149. DOI: 10.1002/pds.4020. View

18.

de Ferranti S, de Boer I, Fonseca V, Fox C, Golden S, Lavie C . Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation. 2014; 130(13):1110-30. DOI: 10.1161/CIR.0000000000000034. View

19.

Kakouros N, Rade J, Kourliouros A, Resar J . Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol. 2011; 2011:742719. PMC: 3159301. DOI: 10.1155/2011/742719. View

20.

Guariguata L, Whiting D, Hambleton I, Beagley J, Linnenkamp U, Shaw J . Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103(2):137-49. DOI: 10.1016/j.diabres.2013.11.002. View